Candida species are a common cause of bloodstream infections and account for 8%-15% of sepsis cases in the United States [1, 2] . The incidence of invasive candidiasis is rising due to advances in medical technology (eg, indwelling catheters, endovascular grafts, and prostheses) and due to increasing numbers of patients with impaired mucosal integrity and defects in innate immune function. The kidney represents the major target organ during candidemia, leading to renal failure as a primary pathophysiologic manifestation of Candida sepsis [3] .
In humans and mice, 2 circulating monocyte subsets can be distinguished by chemokine receptor and adhesion molecule expression [4, 5] flammatory cytokine responses and anticandidal activity in vitro [7] , their role during primary challenge remains undefined [8] . In candidemic mice, Ly6C hi inflammatory monocytes rapidly infiltrate infected kidneys [9] . However, type I interferon [10] and CCR1 signaling [11] have been linked to pathologic and dysregulated immune responses associated with inflammatory monocytes and neutrophils, respectively. Thus, it remains unclear whether monocytes play a protective or detrimental role during systemic candidiasis. Herein, we investigated the specific contribution and temporal requirements of inflammatory monocytes during murine disseminated candidiasis. By harnessing 2 transgenic mouse strains that (1) label inflammatory monocytes with green fluorescent protein (GFP; CCR2 reporter mice) and (2) enable systemic depletion of inflammatory monocytes and their derivatives (CCR2 depleter mice) [12] , we determined that inflammatory monocytes are essential in the first 48 hours postinfection to control fungal growth in the kidneys and brain, but not at other sites. Our studies reveal that inflammatory monocytes and their derivatives mediate an essential protective function at the onset of systemic candidiasis and demonstrate that adoptive transfer can provide a benefit in depleted mice.
MATERIALS AND METHODS

Mice
CCR2 reporter (C2R; CD45.1 + C57BL/6-BAC-Tg[pCCR2-GFP]) [12, 13] and CCR2 depleter (C2D; CD45.2 + C57BL/6-BAC-Tg [pCCR2-DTR-2A-CFP]) [12] , and C57BL/6J ( Jackson Laboratories) mice were bred in the Comparative Medicine Shared Resource Facility at Fred Hutchinson Cancer Research Center (FHCRC) under specific pathogen-free conditions. For data shown in Figure 1 and Figure 2 , CCR2 (−/−) mice (C2K; Jackson Laboratories) and C2R mice were crossed, yielding CCR2
(−/−) C2R (C2KR) mice that are deficient in CCR2 and express GFP under control of the BAC-encoded CCR2 promoter. For data shown in Figure 3A , the F1 progeny from a cross between C2R and C2D mice were used, resulting in littermates that express the DTR and the GFP transgenes (C2DR mice) and in littermates that express GFP, but not the DTR transgene. Experiments were conducted with sex-and age-matched mice and were approved by the FHCRC Institutional Animal Care and Use Committee.
Fungal Strain and Infection Model
The Candida albicans strain SC5314 was grown in yeast extract/peptone/glucose medium at 30°C for 16-18 hours. Mice were infected with 10 5 blastoconidia via the lateral tail vein.
Mice were treated with 10 ng/g body weight diphtheria toxin (DT) intraperitoneally at indicated time points. Mice were monitored for morbidity and euthanized when they showed severe signs of pain, distress, or inability to feed. For colonyforming unit (CFU) determination, the kidneys, brain, spleen, and liver were collected, homogenized in phosphate-buffered saline (PBS) and 0.025% Tween-20, and plated on yeast extract/ peptone/dextrose agar plates.
Generation of Single-Cell Organ Suspensions and Flow Cytometry
Cell suspensions were generated by dissociating kidneys through a 100-µm mesh and digesting tissue fragments in PBS, 5% fetal calf serum (FCS), 2 mg/mL collagenase type IV (Worthington), and 20 U/mL DNase I for 30 minutes at 37°C. Samples were lysed of red blood cells (RBCs) and spun over a 40% Percoll cushion (1000g), and the pellet was washed and resuspended in 2 mL PBS and 5% FCS. The number of CD45 + leukocytes in each sample was quantified using phycoerythrin-conjugated microspheres (Spherotech). Bone marrow cells were flushed from tibias and femurs, lysed of RBCs, and resuspended in PBS and 5% FCS, and enumerated using a Beckman Coulter Z2 particle counter. Cell suspensions were stained with the antibodies anti-Ly6G (1A8), anti-F4/80 (BM8), anti-CD11c (HL3), anti-CD11b (M1-70), anti-Ly6C (AL21), anti-Ly6B.2 (7/4), anti-MHC class II (M5/114.15.2), anti-Ter-119 (TER-119), anti-CD45.1 (A20), and anti-CD45 (30F11). For some experiments, anti-CD3 (145-2C11), anti-CD19 (1D3), anti-CD11c (HL3), anti-NK1.1 (PK136), anti-CD8 (53-6.7), and anti-CD49b (DX5) were used. Flow cytometry was performed on a BD LSR II and cell sorting was performed on a BD FACSAria II (BD Biosciences).
Histopathology
Perfused kidneys were collected 72 or 144 hours postinfection, fixed in 10% neutral-buffered formalin, embedded in paraffin, and sectioned at 2 µm (for hematoxylin and eosin staining) or 4 µm (for periodic acid-Schiff [PAS] staining and methyl green counterstaining) thickness. Images were captured from wholeslide images acquired with the Aperio ScanScope AT using ×20 and ×40 objectives.
In Vitro Candida Killing Assay
Candida albicans (5 × 10 5 blastoconidia) was incubated with bone marrow (BM) monocytes (1 × 10 6 ) in 0.2 mL RP10 (RPMI, 10% FCS, 5 mM HEPES, 1.1 mM L-glutamine, 0.5 U/mL penicillin, 0.5 µg/mL gentamicin, 50 µg/mL streptomycin, and 50 µM 2-mercaptoethanol) in triplicate in a 96-well microplate for 2 hours and 45 minutes at 37°C. Monocytes were lysed with 0.02% Triton-X-100 in water and washed with PBS, and surviving C. albicans cells were incubated with 0.2 mL Alamar Blue (diluted 1:40 in PBS) for 16 hours at 37°C prior to absorbance measurement (OD 570 nm, 600 nm) on a Versamax plate reader. A standard curve to determine C. albicans killing was constructed by measuring the absorbance of a serial 2-fold dilution of C. albicans cells (15. 
Statistical Analysis
A Mann-Whitney U test (for 2 group comparisons) or a Kruskal-Wallis 1-way analysis of variance followed by Dunn multiple comparison tests (for 3 group comparisons) was used for analyses. Survival data were analyzed by log-rank test. All analyses were performed with GraphPad Prism, version 5.0c.
RESULTS
CCR2 and Renal Inflammatory Monocyte Influx During Candidiasis
To characterize the role of CCR2 on renal cellular influx during systemic candidiasis, renal cell suspensions from naive and C. albicans-infected CCR2 reporter (C2R) mice were enumerated and examined by flow cytometry. CD11b + Ly6C hi inflammatory monocytes (Mo) and CD11b + Ly6C + Ly6G + neutrophils (Ne) each constituted <5% of CD45 + renal leukocytes in naive C2R mice ( Figure 1A ). The frequency and absolute number of inflammatory monocytes was reduced in the kidneys of naive CCR2
(−/−) C2R hosts (C2KR mice; Figure 1B and 1E), as expected from previous studies [14, 15] . Beyond inflammatory monocytes, GFP expression was noted in a subset of CD11b + Ly6C The number of inflammatory monocytes was severely reduced in the kidneys of infected C2KR reporter mice ( Figure 1D ), indicating that CCR2-dependent signals direct inflammatory monocyte trafficking during systemic candidiasis. Although CCR2-independent renal monocyte recruitment was observed starting at day 2 postinfection, this pathway accounted for only 10%-20% of renal inflammatory monocyte influx, given the >80% reduction observed in C2KR mice at all time points examined ( Figure 1E ). In C2KR mice, inflammatory monocytes were retained in the bone marrow of infected mice ( Figure 1F ).
CCR2 and Fungal Clearance During Candidiasis
To determine the impact of CCR2-dependent trafficking steps on the outcome of infection, the renal fungal burden was determined in C2KR mice and compared to C2R mice. Two days postinfection, C2KR mice had a higher renal fungal burden than C2R mice, linking CCR2-dependent inflammatory monocyte trafficking to a defect in renal antifungal activity (Figure 2A ). At this time point, renal neutrophil influx was similar in CCR2-deficient Figure 2C ) and C2KR mice (data not shown) succumbed to systemic candidiasis more rapidly than C57BL/6 ( Figure 2C ) and C2R mice (data not shown). Histopathologic examination of PAS-and hematoxylin and eosin (H&E)-stained sections from C2KR mice (6 days postinfection) revealed widespread multifocal and coalescing abscesses consisting of degenerative and nondegenerative neutrophils and cellular debris. Abscesses surrounded foci of pseudohyphae in the renal cortex and medulla (black arrows in Figure 2D , insets in Figure 2Di and 2Dii; Supplementary Figure 3A and 3B). Severe and diffuse papillary necrosis with abundant pseudohyphal tissue invasion (white arrow in Figure 2D ; Supplementary Figure 3A and 3B) and extensive degenerative + cells and murine susceptibility to systemic candidiasis. A, C2DR (white bars) or C2R (gray bars) littermate mice were treated with 10 ng/g body weight diphtheria toxin (DT) on day −1 and day 0 and infected with 10 5 Candida albicans blastoconidia intravenously. The bar graphs indicate the mean (+SEM) of renal inflammatory monocytes at the indicated time points. **P < .01 by Mann-Whitney U test. B, Kaplan-Meier survival of C2D mice (white circles; n = 22) or nontransgenic (non-Tg) littermates (gray circles; n = 14) injected with DT or C2D mice injected with phosphatebuffered saline (PBS; black circles; n = 9) on days −1 and 0 and infected with 10 5 C. albicans blastoconidia. C, C2D and non-Tg littermates were treated with DT (days −1 and 0), infected with 10 5 C. albicans blastoconidia, and euthanized at the indicated time points for colony-forming unit (CFU) analysis. The bar graphs indicate the mean (+SEM) renal CFUs for C2D mice (white bars) and non-Tg littermates (gray bars). Six C2D mice were euthanized prior to day 4 postinfection due to disease severity and were excluded from the analysis. *P < .05 by Mann-Whitney U test. Figure 3A and 3B) .
In C2R mice, kidney sections revealed rare microabscesses in the cortex and medulla ( Figure 2E and 2Ei) , the presence of intratubular neutrophilic infiltrates, and pseudohyphal tissue invasion in the renal papillae (Figure 2Eii and Supplementary Figure 3C and 3D). Sections from C2KR mice consistently displayed more severe and widespread parenchymal inflammation, papillary necrosis, and pseudohyphal tissue invasion than sections from C2R mice, correlating severe pathophysiologic manifestations of invasive candidiasis with loss of CCR2-dependent inflammatory monocyte trafficking.
Depletion of CCR2-Expressing Cells During Systemic Candidiasis and Impact on Infectious Outcome
To address the role of CCR2-independent monocyte trafficking and of CCR2 + renal-resident mononuclear phagocytes in host defense, we depleted CCR2 + cells systemically using an established DT-dependent cell ablation strategy [12] . To monitor the kinetics of DT-induced cell depletion in infected mice, C2D and C2R mice were crossed to obtain F1 progeny that contain GFP + inflammatory monocytes and either express DTR to enable cell ablation (C2DR mice in Figure 3A ) or lack the DTR transgene, rendering CCR2-expressing cells resistant to DT (nontransgenic [non-Tg] littermates in Figure 3A ). All mice were treated with 10 ng/g body weight DT on day −1 and 0, infected with C. albicans, and euthanized at day 2 and day 4 postinfection. DT treatment reduced the number of renal inflammatory monocytes by >99% in naive and in day 2 infected C2RD mice compared to control littermates ( Figure 3A ). Although renal inflammatory monocyte numbers recovered by day 4 postinfection in C2DR mice, many infected C2RD mice appeared moribund and were euthanized ( Figure 3A) . Kaplan-Meier analysis of DT-or PBS-treated C2D as well as DT-treated non-Tg littermates demonstrated a significant increase in mortality in DT-treated C2D mice compared with both control groups ( Figure 3B ). The renal fungal burden in DT-treated C2D mice was 1-2 log 10 higher than in non-Tg littermates at 2 and 4 days postinfection ( Figure 3C ), indicating an innate defect in renal antifungal activity linked to the depletion of CCR2 + cells.
Histopathologic examination of PAS-stained renal sections isolated from DT-treated C2D mice 72 hours postinfection revealed widespread destruction of renal tubules and glomeruli by invasive fungal filaments and abundant yeast cell forms, with large coalescing foci throughout the cortex and medulla ( Figure 3D and 3Di) . Widespread and coalescing areas of lytic and coagulative necrosis were observed in H&E-stained sections. The lesions contained degenerative neutrophil-rich inflammatory infiltrates characterized by cellular debris (Supplementary Figure 3E and 3F). Fungal organisms were observed in subcapsular spaces, within blood vessels, and traversing vessel walls (Figure 3Di and Supplementary Figure 3F ).
In contrast, PAS-stained sections from DT-treated non-Tg littermates contained scattered fungal foci within the renal pelvis and rare yeast cells and hyphae were noted ( Figure 3E and 3Ei). On H&E-stained sections, the medulla contained few focal areas of necrosis and there was mild multifocal tubular degeneration and necrosis with mild multifocal, tubular, and interstitial nondegenerative neutrophilic infiltrates within the cortex and medulla (Supplementary Figure 3G and 3H) . Thus, depletion of CCR2-expressing cells is associated with rapid and severe renal inflammation and widespread parenchymal destruction by invasive C. albicans filaments.
Timing and Organ Specificity of CCR2-Expressing Cells During Systemic Candidiasis
To define the temporal window of CCR2 + leukocyte function, we varied the onset of DT treatment during infection and examined the impact on organ fungal burden ( Figure 4A ). When DT was administered starting 48 hours after onset of systemic candidiasis, C2D mice did not show a defect in renal or brain fungal clearance compared to non-Tg littermates, unlike C2D mice treated with DT prior to infection ( Figure 4B and 4C). These data indicate that CCR2 + cells confer protective antifungal activity during the first 48 hours postinfection, using day 4 organ fungal burden as a readout. Ablation of CCR2-expressing cells in C2D mice led to marginal increases in splenic ( Figure 4D ) and no increases in hepatic fungal burden compared to control mice, irrespective of DT timing ( Figure 4E ). Because DT treatment reduced splenic and hepatic inflammatory monocytes by >99% in C2D mice (data not shown), we conclude that inflammatory monocytes and other CCR2 + cells do not play a major role in C. albicans clearance in these organs. These data indicate that CCR2 + cells are essential for antifungal activity in an organ-specific fashion during systemic candidiasis.
Adoptive Transfer of Inflammatory Monocytes and Restoration of Antifungal Activity in Target Organs
To determine whether inflammatory monocytes account for the phenotype observed in mice depleted of CCR2 + cells, we examined the candidacidal properties of inflammatory monocytes and conducted adoptive transfer experiments to attempt to restore antifungal activity in DT-treated C2D hosts. Sorted CD45.1 + GFP + BM inflammatory monocytes ( Figure 5A ) were incubated ex vivo with C. albicans blastoconidia. Using Alamar Blue reduction as a measure of fungal inactivation, we observed that inflammatory monocytes inactivated approximately 50% of fungal cells using a 2:1 effector to target cell ratio ( Figure 5B ). To extend these findings in vivo, we sorted and transferred 10 6 GFP + BM inflammatory monocytes into DT-treated C2D mice and infected the animals with C. albicans ( Figure 5C ). DT-treated C2D mice that received a monocyte graft had a significantly lower brain and renal fungal burden 4 days postinfection compared to DT-treated C2D mice that did not receive a graft ( Figure 5D and 5E).
In parallel experiments, CD45.1 + renal monocytes recovered from infected mice 60 hours postinfection increased surface expression of CD11c, MHC class II, and F4/80 compared to expression levels in the monocyte graft ( Figure 5F ). Thus, in the context of inflammation, kidney-infiltrating monocytes acquire a flow cytometric phenotype that resembles that of steady-state CCR2 + renal mononuclear phagocyte populations, although
Ly6C expression remains elevated (not shown). These data indicate that loss of renal antifungal activity in DT-treated C2D mice is largely attributable to depletion of inflammatory monocytes and their derivatives. 
DISCUSSION
Although inflammatory monocyte mobilization to foci of microbial infection is a common feature of the murine immune response to a broad range of pathogens [16, 17] , the role of monocytes as innate antifungal effector cells remains poorly understood. In this study, we find that inflammatory monocytes and their derivatives play an early and essential antifungal role and provide a protective benefit in a temporal and compartment-specific fashion during systemic candidiasis. The presence and recruitment of inflammatory monocytes and their derivatives in target organs leads to more effective fungal growth control and to increased host survival compared to monocytopenic control groups. The protective benefit associated with inflammatory monocytes during invasive candidiasis was preserved in an adoptive transfer setting, consistent with an intrinsic innate antifungal effector function.
We examined infectious outcomes in C2K and in C2D mice to distinguish the role of CCR2-dependent mobilization from the role of CCR2 + cells in systemic candidiasis. In C2K mice,
we observed a minor reduction in renal inflammatory monocyte numbers at baseline (on the order of 10 4 cells) and a major reduction in renal inflammatory monocyte recruitment during early candidiasis (on the order of 10 5 cells at 24 hours postinfection); both of these processes likely underlie the enhanced susceptibility of C2K mice compared to CCR2-sufficient controls.
The more prominent phenotype observed in C2D mice compared to C2K mice likely relates to several points. First, inflammatory monocyte renal trafficking is curtailed by 80%-90% in CCR2
(−/−) mice, but it is not fully abolished as it is in C2D mice.
Second, resident CCR2 + mononuclear phagocytes, including F4/ 80 + macrophages and CD11b + DCs, represent constituents of a mononuclear phagocyte network [18] that likely contributes to candidal defense in a CCR2-independent manner. The finding that tissue-infiltrating inflammatory monocytes upregulate F4/ 80, CD11c, and MHC class II expression suggests a developmental relationship between circulating and renal-resident mononuclear phagocytes, though further studies are necessary to clarify the ontogeny of renal mononuclear cell populations. Our data do not preclude a role for CCR2 + NK cells in antifungal host defense, as has been demonstrated in a neutropenic model of invasive aspergillosis [19] . However, during early stages of systemic candidiasis, we did not observe numeric expansion of CCR2 + NK cells, and adoptive transfer of purified inflammatory monocytes reversed the phenotype of CCR2-depleted mice to a substantial extent. The paradigm of inflammatory monocyte-dependent protective antimicrobial activity was established in systemic listeriosis, based on the observation that CCR2-dependent trafficking cues are essential for the formation of tumor necrosis factor (TNF)-and iNOS-producing dendritic cells (Tip-DCs) [20] , an inflammatory monocyte-derived population that acts as essential innate effector cell [21] . However, innate antimicrobial properties of inflammatory monocytes and their derivatives can be outweighed by the development of immunopathology, as observed in influenza [22, 23] , amebiasis [24] , and trypanosomiasis [25] . In these models, loss of CCR2 signaling reduced inflammatory monocyte accumulation at foci of infection, leading to reduced organ damage and enhanced host survival. During trypanosomiasis, IFN-γ and MyD88-dependent signals regulate the maturation of Ly6C hi monocyte-derived Tip-DCs, a process that can be blocked and therapeutically regulated by the action of interleukin 10 [25, 26] . Previous studies in mice with disseminated candidiasis have raised a potential pathologic role of Ly6C hi inflammatory monocytes during the infection process, particularly at late time points. Romani and colleagues demonstrated that murine survival could be ameliorated if leukocytes that express Gr-1 an epitope predominately found on neutrophils but also on Ly6C hi inflammatory monocytes, were targeted for depletion at late time points postinfection [27] . Consistent with the notion that dysregulated phagocyte activity contributes to the pathogenesis of systemic candidiasis, loss of type I interferon improved host survival but did not accelerate renal candidal clearance [10] . Loss of type I interferon signaling induced an early and partial defect in the recruitment and activation of Ly6C hi monocytes into iNOS-producing derivatives and induced a dramatic reduction in renal neutrophil influx at late time points. Administration of the peroxisome proliferator-activated receptor γ ligand pioglitazone, a repressor of CCR2 promoter activity [28] , reduced the inflammatory pathology driven by type I interferon signaling [10] , linking CCR2 promoter activity to the induction or amplification of pathways that mediate late immunopathology during candidiasis. However, Ly6C hi monocytes were minor constituents of the pathologic effector cell population in the kidneys of mice during the time period when immune-mediated damage led to diminished organ function. The finding that CCR1 signaling led to pathologic renal neutrophil, but not Ly6C hi monocyte, accumulation during the second week of infection reinforces this notion [11] . Whether Ly6C hi monocytes mediate the induction of CCR1 ligands in infected kidneys remains unknown, though our data suggest that disruption of CCR2-dependent monocyte trafficking to infected kidneys did not influence renal neutrophil influx. Thus, dysregulated renal neutrophil influx appears to be the primary mechanism that drives the late immunopathology in mice with systemic candidiasis. Previous studies in respiratory fungal infection models have illustrated an obligate role for inflammatory monocytes and their derivatives in regulating CD4 T-cell responses. In a pulmonary aspergillosis and in a blastomycosis vaccination model, inflammatory monocytes differentiated into CD11b + monocyte-derived
DCs that engulfed and transported fungal cells to organ-draining lymph nodes [12, 29] . This trafficking step was essential for the priming of fungus-specific CD4T cells. Furthermore, depletion of inflammatory monocytes resulted in a shift from a predominant Th1 to a Th17 differentiation program by regulating T-bet expression in Aspergillus fumigatus-specific CD4T cells [30] . During pulmonary cryptococcosis, disruption of CCR2 signaling resulted in the development of a nonprotective Th2-biased response [31] that correlated with impaired monocyte pulmonary influx, reduced numbers of monocyte-derived pulmonary DCs [32] , and delayed cryptococcal clearance. Our study extends these findings to identify antifungal properties of monocytes during the earliest stages of disseminated fungal infection. Consistent with this view, our laboratory developed a fluorescent A. fumigatus reporter (FLARE) strain that indicates conidial uptake by and viability in host leukocytes with single encounter resolution [33] . In this respiratory fungal infection model, CD11b + monocytederived DCs have the capacity to bind, internalize, and inactivate A. fumigatus conidia in the lung [33] and represent a major TNFproducing cell population in neutropenic mice [34] . However, it remains to be elucidated whether inflammatory monocytes and their derivatives represent a major and direct fungicidal effector cell population during respiratory fungal infection.
Our studies indicate that inflammatory monocytes can inhibit C. albicans growth in vitro and in vivo. The recent development of mouse strains that permit conditional gene knockouts in monocytes [35] will undoubtedly facilitate studies to elucidate the signaling pathways and effector molecules that regulate their antifungal properties in vivo. Given the growing population of immunocompromised patients with functional and numeric deficits in phagocyte activity and the increasing incidence of antifungal drug resistance, pursuing strategies to harness and augment the antifungal activity of monocytes for therapeutic gain is highly relevant for improving patient outcomes.
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